Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Vivian Park"'
Autor:
Jung Hyun Yoon, Haesung Yoon, Eun-Kyung Kim, Hee Jung Moon, Youngjean Vivian Park, Min Jung Kim
Publikováno v:
Ultrasonography, Vol 36, Iss 4, Pp 310-320 (2017)
Nipple discharge is a common symptom that is alarming for the patient since it can be a presenting symptom of breast cancer. Breast imaging is used to examine women with pathologic nipple discharge in order to detect any lesions that may be present a
Externí odkaz:
https://doaj.org/article/17e9e2f124ee46379a8eadc3cc2e637a
Publikováno v:
The Oncologist. 27:e755-e758
Background Little is known about patient outcomes with advanced melanoma following inpatient initiation or continuation of immune checkpoint blockade (ICB). Methods and Results We conducted a single institution retrospective case series of advanced m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c561ae21f642d383bf0294875cea3d82
https://doi.org/10.1093/oncolo/oyac121
https://doi.org/10.1093/oncolo/oyac121
Autor:
Ga Ram Kim, Jee Ye Kim, Si Eun Lee, Jung Hyun Yoon, Youngjean Vivian Park, Min Jung Kim, Ha Yan Kim, Hee Jung Moon, Eun Kyung Kim
Publikováno v:
Annals of Surgical Oncology. 28:8699-8709
Because no prior studies have evaluated the chronological trends of ductal carcinoma in situ (DCIS) despite the increasing number of surgeries performed for DCIS, this study analyzed how the clinical, radiologic, and pathologic characteristics of DCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1412c569b5b72e141b0e827606fcb784
https://doi.org/10.1245/s10434-021-10378-3
https://doi.org/10.1245/s10434-021-10378-3
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 20(10)
Background: Whether COVID-19 vaccination and the associated immune response increases susceptibility to immune-related adverse events (irAEs) among patients treated with immune checkpoint inhibition (ICI) remains unknown. Short-term follow-up can ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29509079650a7616fdf4a0fdfc062f4
https://pubmed.ncbi.nlm.nih.gov/36240845
https://pubmed.ncbi.nlm.nih.gov/36240845
Autor:
Eun Kyung Kim, Jung Hyun Yoon, Jai Kyung You, Youngjean Vivian Park, Jung Hee Byon, Min Jung Kim, Hee Jung Moon
Publikováno v:
Radiology. 300(1)
Background In the post-American College of Surgeons Oncology Group Z0011 trial era, radiologists have increasingly focused on excluding high-level or advanced axillary lymph node metastasis (ALNM) by using an additional MRI scan positioned higher tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b817ae9688ed10dd38d1e6655a9b8e43
https://pubmed.ncbi.nlm.nih.gov/33908796
https://pubmed.ncbi.nlm.nih.gov/33908796
Autor:
Bevin Cohen, Mini Kamboj, Michael A. Postow, Jedd D. Wolchok, Vivian Park, Curtis Robert Chong
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Cancer patients are at a higher risk for developing influenza (flu)– related complications. It is unclear if the flu vaccine exacerbates immune events in patients treated with immune checkpoint inhibitors (ICIs). Methods We conducted an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b56ce9d62b5534899b075f859ef40e2
https://pubmed.ncbi.nlm.nih.gov/31210266
https://pubmed.ncbi.nlm.nih.gov/31210266
Autor:
Rona Yaeger, Leonard B. Saltz, Anna M. Varghese, Nancy E. Kemeny, Andrea Cercek, Vivian Park, Zsofia K. Stadler, Neil H. Segal, Diane Reidy-Lagunes
Publikováno v:
Journal of Oncology Practice. 12:e548-e553
Purpose: Oxaliplatin at a dose of 85 mg/m2 traditionally has been administered over 120 min in the standard FOLFOX (infusional fluorouracil, leucovorin, and oxaliplatin) regimen. CapeOx (capecitabine plus oxaliplatin), in which the dose of oxaliplati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ace51a05bf3584ffb6b066727289d0
https://doi.org/10.1200/jop.2015.008417
https://doi.org/10.1200/jop.2015.008417
Autor:
Katherine S. Panageas, Michael A. Postow, Parisa Momtaz, Paul B. Chapman, Vivian Park, Jedd D. Wolchok, Margaret K. Callahan
Publikováno v:
Journal of Clinical Oncology. 33:3454-3458
Purpose The approved dose of ipilimumab is 3 mg/kg infused over 90 minutes; however, in clinical trials, 10 mg/kg has also been infused over 90 minutes. At this higher dose, patients receive 3 mg/kg within the first 27 minutes of treatment. We sought
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa7772209ca90f851172a465501f8d1
https://doi.org/10.1200/jco.2015.61.0030
https://doi.org/10.1200/jco.2015.61.0030
Autor:
Prabalini Rajendram, Louis Voigt, Sunil Kamat, Vivian Park, Sanjay Chawla, Neil A. Halpern, Natalie Kostelecky, Stephen M. Pastores
Publikováno v:
Critical Care Medicine. 40:1-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee665c051743e9ffcefec04f2225699d
https://doi.org/10.1097/01.ccm.0000424641.07134.30
https://doi.org/10.1097/01.ccm.0000424641.07134.30
Publikováno v:
Journal of Clinical Oncology. 36:e15073-e15073
e15073Background: Cancer patients (pts) are at a higher risk for developing influenza related complications. It is unclear if vaccination against influenza exacerbates adverse events in patients un...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c4df7a072c3eba4875c9a33f77dab4
https://doi.org/10.1200/jco.2018.36.15_suppl.e15073
https://doi.org/10.1200/jco.2018.36.15_suppl.e15073